Others 8

Others 8

Others 8 related products

Structure Cat No. Product Name CAS No. Product Description
V4380 AVELUMAB 1537032-82-8 Avelumab (Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C; trade name Bavencio) is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
V4244 AZD 4407 166882-70-8 AZD 4407 is a novel, potent and selective 5-lipoxygenaseinhibitor.
V4353 AZD-0284 2101291-07-8 AZD-0284 is a novel,potent, selective, inverse agonist of the nuclear receptorRORγ.
V4343 AZD-5991 S-ENANTIOMER 2143061-82-7 AZD-5991 S-enantiomer, theS-enantiomer of AZD-5991, is the less active enantiomer of AZD-5991.
V4236 AZD1979 1254035-84-1 AZD1979 is anovel and potent antagonist ofMelanin-concentrating hormone receptor 1(MCHr1) with anIC50of ~12 nM.
V4352 AZD2066 934282-55-0 AZD-2066 is a potent, selective, orally bioavailable and brain penetrant antagonist mGlu5 (metabotropic glutamate receptor 5) with IC50 in the nanomolar range for rat and human receptors, respectively.
V2115 AZD7687 1166827-44-6 AZD7687 is a novel, potent, selective,reversible and pyrazinecarboxamide-based inhibitor of diacylglycerol acyltransferase 1 (DGAT1) with an IC50 value of 80 nM for hDGAT1.
V4253 AZD9056 345304-65-6 AZD9056 is a novel, potent, selective, orally bioavailable antagonist of P2X7 receptor which is an adenosine triphosphate (ATP)-gated cation channel expressed on a variety of cell types believed to play a role in inflammation.
V2195 AZD9977 1850385-64-6 Balcinrenone (AZD9977) is a potent, selective, orally bioactive mineralocorticoid receptor (MR) modulator.
V4186 BAY-1316957 1613264-40-6 BAY-1316957 (BAY1316957) is a novel, highly potent, selective, and orally bioavailable antagonist of human prostaglandin E2 receptor subtype 4 (hEP4 receptor) with the potential to be usedfor the Treatment of Endometriosis.
V4170 BAY-320 1445830-50-1 BAY-320 is a novel and potent Bub1 inhibitor with anIC50of 680 nM for human Bub1 in the presence of 2 mM ATP.
V4189 BAY-Y 3118 151213-16-0 BAY-Y 3118 is novel and potent chlorofluoroquinolone derivative with antimicrobial activity againstHaemophilhs influenzae, Moraxela catarrhalis, Acinetobacter baumannii, Xanthomonas maltophiia, gram-positive cocci, and anaerobes; MICs for 50%o of the strains (MIC50s) and MIC90s are ≤0.015 and ≤0.015, ≤0.015 and ≤0.015, 0.03 and 2, 0.25 and 0.5, 0.06 and 1, and 0.12 and 0.25 μg/mL, respectively.
V2398 Benzamide HCl Benzamide HCl is a potent FTO inhibitor with the potential to be used for treatingobesity, breast cancers, pancreatic cancer, and Alzheimers diseases.
V3955 BESIFOVIR 441785-26-8 Besifovir (formerly known as ANA-380; LB-80380; PMCDG dipivoxil; Korea Trade name: Besivo) is a reverse transcriptase inhibitor that has been approved in Korea to treat hepatitis B virus (HBV) infection.
V3956 BESIFOVIR MALEATE 1039623-01-2 Besifovir maleate (formerly known as ANA-380 maleate; LB-80380 maleate; PMCDG dipivoxil maleate; Korea Trade name: Besivo) is a reverse transcriptase inhibitor that has been approved in Korea to treat hepatitis B virus (HBV) infection.
V2112 BET-BAY 002 1588521-78-1 BET-BAY 002 is a novel and potentBET(Bromodomainand extra-terminal) inhibitor whichexhibits high efficacy in a multiple myeloma model.
V4373 BEVACIZUMAB 216974-75-3 Bevacizumab (trade nameAvastin; Anti-Human VEGF, Humanized Antibody) is a humanized monoclonal antibody which binds specifically to allVEGF-Aisoforms with high affinity.
V2121 BIIE-0246 (AR-H 053591) 246146-55-4 BIIE0246 (BIIE-0246) is a newly synthesized, potent and highly selective non-peptide neuropeptide Y (NPY) Y2 receptor antagonist with an IC50 of 15 nM.
V0712 BioE-1115 1268863-35-9 BioE-1115 (BioE 1115) is a novel, potent and highly selectivePAS kinase (PASK)inhibitor with anIC50of ~4 nM, it is also a potentcasein kinase 2αinhibitor with anIC50of ~10 μM.
V2060 BMS 433796 935525-13-6 BMS 433796 is a novel and potentγ-secretaseinhibitor withAβlowering activity in a transgenic mouse model of Alzheimers disease.
Contact Us Back to top